Cover Image
市場調查報告書

中國的非侵入性產前診斷 (NGS-NIPT) 用次世代定序

Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) in China

出版商 Kalorama Information 商品編碼 363406
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
中國的非侵入性產前診斷 (NGS-NIPT) 用次世代定序 Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) in China
出版日期: 2016年06月29日 內容資訊: 英文 37 Pages
簡介

本報告提供中國的非侵入性產前診斷 (NGS-NIPT) 用次世代定序市場相關調查,市場預測,市場佔有率,醫院的GNS的資料,NGS實施設施,主要的設備廠商,服務供應商,及主要NGS企業的簡介等。

第1章 摘要整理

第2章 簡介

  • 中國的觀點
  • 人口趨勢、人口統計
    • 人口高齡化
  • 中國的醫院市場成長
    • 中國的醫院數
    • 中國的醫院:各級 (I級,II級,III級)
    • 醫院的資源的規定
  • 智慧財產權的問題
  • 中國的自我負擔費用高
    • 自我負擔費用的比例:中國 vs. 其他各國
  • 醫療制度改革
  • 疾病的成本
  • 定序的簡介
    • Sanger法
    • 次世代定序
    • 中國的定序
    • 產品認證
    • 在中國實施NGS的設施
  • 新生兒篩檢所採用的技術
    • 傳統檢驗
    • 定序

第3章 市場分析

  • 簡介
    • 相關的人口統計
  • NGS醫院利用
    • 使用NGS的醫院:外包 vs. 公司內部
  • 主要的競爭企業
    • 中國的次世代定序的主要企業 (設備供應商,實驗廠商,服務供應商)
  • 中國的NGS-NIPT市場
    • 市場規模、預測
    • 中國的NGS-NIPT的市場佔有率及競爭分析
    • 中國的新興NGS應用
  • 中國的NGS競爭企業
    • Annoroad
    • Amoy Diagnostics Co., LTD
    • Berry Genomics Co. Ltd
    • Beijing Genomics Institute (BGI)
    • CapitalBio Corporation
    • Novogene
    • Daan Gene Co., Ltd.
    • Shanghai Kehua Bio-engineering
    • Zhejiang Dian Diagnostics
    • Wuxi AppTec Co. LTD.
目錄
Product Code: KLI15042533

The stakes are high for clinical next-generation sequencing (NGS) platform vendors in the Chinese market. Already home to a significant amount of all laboratories worldwide providing clinical genetic testing services, China is playing an increasingly significant role not only in the IVD industry, but in global clinical markets.

This report, Next Generation Sequencing for NIPT in China estimates the market for Non Invasive Prenatal Testing in this emerging market, and generally examines the role of next generation sequencing in the company. The report provides information on approved NGS instruments, Chinese institutions using NGS, companies that offer NIPT services as well as definitive market size and share for this market.

As part of its market analysis this report includes:

  • Market for Non-Invasive Prenatal Testing using Sequencing in China
  • Forecast to 2020
  • Market Share
  • Hospital NGS in China Data
  • Institutions Performing NGS
  • Key Equipment Manufactuers and Service Providers
  • Chinese NGS Company Profiles

Despite slackened economic growth, the country remains a source of tremendous demand for clinical innovation and higher standards of care. Outside of North America, Europe and Japan, China is primed to emerge as the leading market for clinical NGS and molecular cancer testing.

This report was created as a cooperative project between Kalorama Information and The Freedonia Group, with staff from Freedonia's Beijing office completing primary and secondary research. Information for this report was gathered from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts' reports and other sources. Interviews with industry experts were conducted to capture the perspectives from market participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Table of Contents

Chapter One: Executive Summary

  • Scope and Methodology
  • Major Findings of The Report

Chapter Two: Introduction

  • China in Perspective
  • Population Trends and Demographics
    • Aging of Population
  • Growing Chinese Hospital Sector
    • Number of Hospitals in China, 2004-2015
    • Hospitals in China by Class (Class I, Class II, Class III)
    • Resource Constraints in Hospitals
  • Intellectual Property Issues
  • Higher Out of Pocket Spending in China
    • Percent of Spending Out of Pocket: China vs. Other Nations
  • Healthcare Reform
  • Disease Costs
  • Sequencing Introduction
    • Sanger
    • Next Generation Sequencing
    • Sequencing in China
    • Products Approved
    • Institutions Performing NGS in China
  • Technologies Used for Newborn Screening
    • Traditional Tests
    • Sequencing

Chapter Three: Market Analysis

  • Introduction
    • Relevant Demographics
  • Hospital Use of NGS
    • Hospitals Using NGS: Outsourced vs. In-House
  • Major Competitors
    • Leading Companies in Next Generation Sequencing in China (Equipment
    • Providers, Test Makers, Service Providers)
  • Chinese NGS-NIPT Market
    • Market Size and Forecast to 2020
    • Market Share of NGS-NIPT in China and Competitive Analysis
    • Emerging NGS Applications in China
  • NGS Competitors in China
    • Annoroad
    • Amoy Diagnostics Co., LTD
    • Berry Genomics Co. Ltd
    • Beijing Genomics Institute (BGI)
    • CapitalBio Corporation
    • Novogene
    • Daan Gene Co., Ltd.
    • Shanghai Kehua Bio-engineering
    • Zhejiang Dian Diagnostics
    • Wuxi AppTec Co. LTD.
Back to Top